Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
47.6M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
35.1M
-
Shares change
-
-106K
-
Total reported value, excl. options
-
$213M
-
Value change
-
+$270K
-
Put/Call ratio
-
1.33
-
Number of buys
-
13
-
Number of sells
-
-10
-
Price
-
$6.06
Significant Holders of ESSA Pharma Inc. - Common Shares (EPIX) as of Q3 2024
38 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares as of Q3 2024.
ESSA Pharma Inc. - Common Shares (EPIX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.1M shares
of 47.6M outstanding shares and own 73.74% of the company stock.
Largest 10 shareholders include BVF INC/IL (8.75M shares), Bellevue Group AG (7.88M shares), Soleus Capital Management, L.P. (4.29M shares), MORGAN STANLEY (4.18M shares), RTW INVESTMENTS, LP (3.26M shares), PFM Health Sciences, LP (2.74M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.47M shares), Rhenman & Partners Asset Management AB (805K shares), Rock Springs Capital Management LP (677K shares), and Parkman Healthcare Partners LLC (346K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.